<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04089917</url>
  </required_header>
  <id_info>
    <org_study_id>101347</org_study_id>
    <nct_id>NCT04089917</nct_id>
  </id_info>
  <brief_title>A Study of the Use of the Q Aspiration Catheter to Remove Clot in Stroke Patients</brief_title>
  <acronym>TAPAS</acronym>
  <official_title>An Observational Study of the Q Aspiration Catheter Used During Neurointervention for Acute Large Vessel Ischemic Stroke in Spain.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>MIVI Neuroscience, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>MIVI Neuroscience, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect real-world safety and performance data on the MIVI
      Neuroscience, Inc. Q Aspiration Catheter for use in the removal of fresh, soft emboli and
      thrombi in the neurovascular system during acute ischemic stroke.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to demonstrate the safety and performance of the MIVI
      Neuroscience, Inc. CE Marked Q Aspiration Catheter for use in the removal of fresh, soft
      emboli and thrombi in the neurovascular system during acute ischemic stroke. The study is an
      observational study collecting Q Aspiration Catheter use that will enroll a maximum of 50
      subjects at a maximum of 5 sites in Spain. Subjects data will be collected through
      hospitalization with a 3 months post-procedure study visit. This study is designed for
      observational data to be collected and reported.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 16, 2019</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Successful revascularization rate</measure>
    <time_frame>intra-procedural</time_frame>
    <description>Defined as final modified Thrombolysis In Cerebral Infarction scale (mTICI 2b-3) flow in the target vessel</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptomatic intracranial haemorrhage rate</measure>
    <time_frame>24 hours post procedure</time_frame>
    <description>Defined as the symptomatic intracranial haemorrhage as detected by CT/MRI with an NIHSS change of &gt;/= 4 points</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Successful revascularization rate using the Q Aspiration Catheter alone</measure>
    <time_frame>intra-procedural</time_frame>
    <description>Defined as mTICI 2b-3 flow in the target vessel post-treatment with the Q Catheter (first line therapy)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of embolization to a new neurovascular territory (ENT)</measure>
    <time_frame>intra-procedural</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Good functional outcome measured by Modified Rankin Scale score of 0-2</measure>
    <time_frame>90 days</time_frame>
    <description>The Modified Rankin Scale (mRS) measures neurological disability or dependence for stroke patients on a scale of 0 (no symptoms) to 6 (deceased).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality rate</measure>
    <time_frame>90 days</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Stroke, Ischemic</condition>
  <arm_group>
    <arm_group_label>Q Aspiration Catheter</arm_group_label>
    <description>mechanical thrombectomy for acute ischemic stroke</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Q Aspiration Catheter</intervention_name>
    <description>The Q Aspiration Catheter is indicated for use in the removal of fresh, soft emboli and thrombi in the neurovascular system.</description>
    <arm_group_label>Q Aspiration Catheter</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Population is patients diagnosed with large vessel occlusion acute ischemic stroke within 8
        hours of stroke onset treated with mechanical aspiration thrombectomy with the Q Aspiration
        Catheter as first line therapy.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 to 85 years;

          -  Diagnosis of acute ischemic stroke with mechanical thrombectomy procedure &lt; 8 hours
             from onset of symptoms/ last known well;

          -  Large Vessel Occlusion on CT or MRI in the anterior cerebral vasculature up to A1, M1,
             or M2 or the posterior cerebral vasculature;

          -  ASPECTS 6 - 10 or volume of diffusion restriction &lt; 50 mL;

          -  Use of the Q Aspiration Catheter as the first line treatment according to the IFU;

          -  Signed informed consent by patient or legally authorized representative.

        Exclusion Criteria:

          -  Occlusions in multiple vascular territories, extracranial occlusion or tandem
             occlusion;

          -  Evidence of dissection in the carotid or target artery for treatment;

          -  Evidence of recent/fresh haemorrhage on presentation;

          -  Unwilling to agree to a 3-month follow up visit.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mariano Espinosa de Rueda Ruiz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neurorradiologia Intervencionista, HCUVA, Murcia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario 12 De Octubre</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Arrixaca</name>
      <address>
        <city>Murcia</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalario Universitario Donostia</name>
      <address>
        <city>San Sebasti√°n</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Santiago de Compostela</name>
      <address>
        <city>Santiago De Compostela</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>August 21, 2019</study_first_submitted>
  <study_first_submitted_qc>September 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2019</study_first_posted>
  <last_update_submitted>June 11, 2020</last_update_submitted>
  <last_update_submitted_qc>June 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mechanical thrombectomy</keyword>
  <keyword>Acute ischemic stroke</keyword>
  <keyword>neurovascular intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

